SVF Endurance (Cayman) Ltd and Related Entities Sell Shares in Vir Biotechnology, Inc.

SVF Endurance (Cayman) Ltd, along with related entities SoftBank Vision Fund (AIV M1) L.P. and SB Investment Advisers (UK) Ltd, reported the sale of shares in Vir Biotechnology, Inc. (VIR) pursuant to a Rule 10b5-1 trading plan. The transactions occurred on October 24, 2025, and October 27, 2025. On October 24, 2025, 46,696 shares were sold at a weighted average price of $5.9595 per share. On October 27, 2025, 66,403 shares were sold at a weighted average price of $6.0477 per share. Following these transactions, SVF Endurance (Cayman) Ltd held 14,664,939 and 14,598,536 shares respectively. The sales were executed in multiple transactions within specified price ranges, and the reporting entities have committed to providing detailed information upon request.